Relevant results have demonstrated that EBI3 was higher expressed in melanoma and the silencing of EBI3 using commercial small interfering RNAs could suppress the malignant phenotypes of melanoma cells as well as modulate the macrophage polarization. The gene discussed is EBI3; the disease is melanoma.